A National Review of Insurance Coverage of Noncancerous Breast Reconstruction.
Journal
Annals of plastic surgery
ISSN: 1536-3708
Titre abrégé: Ann Plast Surg
Pays: United States
ID NLM: 7805336
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
4
9
2021
Statut:
ppublish
Résumé
Breast reconstruction is commonly performed for a multitude of noncancerous indications, such as correction of congenital deformities, acquired tissue disease, burns, and trauma. However, breast reconstruction for noncancerous indications is often considered cosmetic or not explicitly mentioned in insurance policies. The goal of this study was to assess variability in insurance coverage of breast reconstruction for noncancerous indications. The authors conducted a cross-sectional analysis of 102 US insurance companies, including Medicare and Medicaid, for coverage of breast reconstruction for noncancerous indications (Poland syndrome, fibrocystic breast disease, burns and trauma). Insurance companies were selected based on their state enrollment data and market share. A Web-based search and individual telephone interviews were conducted to identify the policy. Medical necessity criteria were abstracted from publicly available policies. Half of the insurers (49%, n = 50) had no policy for Poland syndrome, 46% (n = 47) had no policy for burns and trauma, and 82% (n = 84) had no policy for fibrocystic breast disease. Fifty-two percent (n = 22) of policies providing coverage for Poland syndrome, 24% (n = 13) of policies providing coverage for burns and trauma, and 58% (n = 7) of policies providing coverage for fibrocystic breast disease had specific, stringent criteria for medical necessity. Thirty-six percent (n = 15) of policies covering Poland syndrome, 47% (n = 26) of policies covering burns and trauma, and 33% (n = 4) of policies covering fibrocystic breast disease include coverage of the contralateral breast. There is a paucity of publicly available information on insurance coverage of breast reconstruction for noncancerous indications and a lack of consensus between top US insurance companies on what constitutes medical necessity for surgical correction.
Sections du résumé
BACKGROUND
Breast reconstruction is commonly performed for a multitude of noncancerous indications, such as correction of congenital deformities, acquired tissue disease, burns, and trauma. However, breast reconstruction for noncancerous indications is often considered cosmetic or not explicitly mentioned in insurance policies. The goal of this study was to assess variability in insurance coverage of breast reconstruction for noncancerous indications.
METHODS
The authors conducted a cross-sectional analysis of 102 US insurance companies, including Medicare and Medicaid, for coverage of breast reconstruction for noncancerous indications (Poland syndrome, fibrocystic breast disease, burns and trauma). Insurance companies were selected based on their state enrollment data and market share. A Web-based search and individual telephone interviews were conducted to identify the policy. Medical necessity criteria were abstracted from publicly available policies.
RESULTS
Half of the insurers (49%, n = 50) had no policy for Poland syndrome, 46% (n = 47) had no policy for burns and trauma, and 82% (n = 84) had no policy for fibrocystic breast disease. Fifty-two percent (n = 22) of policies providing coverage for Poland syndrome, 24% (n = 13) of policies providing coverage for burns and trauma, and 58% (n = 7) of policies providing coverage for fibrocystic breast disease had specific, stringent criteria for medical necessity. Thirty-six percent (n = 15) of policies covering Poland syndrome, 47% (n = 26) of policies covering burns and trauma, and 33% (n = 4) of policies covering fibrocystic breast disease include coverage of the contralateral breast.
CONCLUSIONS
There is a paucity of publicly available information on insurance coverage of breast reconstruction for noncancerous indications and a lack of consensus between top US insurance companies on what constitutes medical necessity for surgical correction.
Identifiants
pubmed: 34397512
doi: 10.1097/SAP.0000000000002871
pii: 00000637-202109000-00002
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
232-237Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
ASPS National Clearinghouse of Plastic Surgery Procedural Statistics. Plastic Surgery Statistics Report. Published online 2020. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2019/plastic-surgery-statistics-full-report-2019.pdf . Accessed October 12, 2020.
Breast Reconstruction Options. https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/breast-reconstruction-options.html . Accessed October 12, 2020.
Women's Health and Cancer Rights Act (WHCRA) | CMS. Available at https://www.cms.gov/CCIIO/Programs-and-Initiatives/Other-Insurance-Protections/whcra_factsheet . Accessed October 12, 2020.
American Society of Plastic Surgeons. ASPS Recommended Insurance Coverage Criteria for Third-Party Payers: Breast Reconstruction for Deformities Unrelated to Cancer Treatment. Published online September 26, 2018. Available at https://www.plasticsurgery.org/Documents/Health-Policy/Reimbursement/insurance-2018-breast-reconstruction-deformities.pdf . Accessed November 15, 2020.
Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist . 2006;11:435–449.
Caouette-Laberge L, Borsuk D. Congenital anomalies of the breast. Semin Plast Surg . 2013;27:36–41.
Mahoney MC, Ingram AD. Breast emergencies: types, imaging features, and management. AJR Am J Roentgenol . 2014;202:W390–W399.
Ho Quoc C, Bouguila J, Brun A, et al. Traitement chirurgical des séquelles de brûlures profondes du sein : 25ans d'expérience. Ann Chir Plast Esthet . 2012;57:35–40.
Baldelli I, Baccarani A, Barone C, et al. Consensus based recommendations for diagnosis and medical management of Poland syndrome (sequence). Orphanet J Rare Dis . 2020;15:201.
Genova R, Garza RF. Breast fat necrosis. In: StatPearls . StatPearls Publishing; 2020. Available at http://www.ncbi.nlm.nih.gov/books/NBK542191/ . Accessed December 7, 2020.
Atisha D, Alderman AK, Lowery JC, et al. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan breast reconstruction outcomes study. Ann Surg . 2008;247:1019–1028.
Papadopulos NA, Eder M, Stergioula S, et al. Women's quality of life and surgical long-term outcome after breast reconstruction in Poland syndrome patients. J Women's Health (Larchmt) . 2011;20:749–756.
Ngaage LM, Knighton BJ, McGlone KL, et al. Health insurance coverage of gender-affirming top surgery in the United States. Plast Reconstr Surg . 2019;144:824–833. doi:10.1097/PRS.0000000000006012.
doi: 10.1097/PRS.0000000000006012
Henry J. Kaiser Foundation. Market share and enrollment of largest three insurers: Individual market. Available at: https://www.kff.org/private-insurance/state-indicator/market-share-and-enrollment-of-largest-three-insurers-indi- vidual-market/?currentTimeframe=0&sortModel=%7B%22 colId%22:%22Location%22,%22sort%22:%22asc%22%7D . Accessed October 12, 2020.
National Association of Insurance Commissioners. 2017 market share reports for the top 125 accident and health insurance groups and companies by state and countrywide. Available at: https://www.naic.org/prod_serv/MSR-HB-18.pdf . Accessed October 12, 2020.
Bureau UC. Health insurance coverage in the United States: 2019. The United States Census Bureau. Available at https://www.census.gov/library/publications/2020/demo/p60-271.html . Accessed February 1, 2021.
Mcd search. Available at https://www.cms.gov/medicare-coverage-database/new-search/search.aspx . Accessed December 13, 2020.
Poland syndrome: MedlinePlus Genetics. Available at https://medlineplus.gov/genetics/condition/poland-syndrome/ . Accessed October 12, 2020.
Sanders C, Cipolla J, Stehly C, et al. Blunt breast trauma: is there a standard of care? Am Surg . 2011;77:1066–1069.
Daya M, Balakrishnan T. Surgery for giant tumours of the breast: a 15 year review. S Afr J Surg . 2018;56:9–15.
Malherbe K, Fatima S. Fibrocystic Breast Disease. In: StatPearls . StatPearls Publishing; 2020: Available at http://www.ncbi.nlm.nih.gov/books/NBK551609/ . Accessed October 12, 2020.
Kasielska-Trojan A, Zieliński T, Pisera P, et al. Comparison of objective and subjective evaluation of breast symmetrization results in patients with Poland syndrome. Pol Przegl Chir . 2018;90:25–28.